This announcement is a separate document:
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
09:05
Sumitomo Mitsui is expected to exceed 7.65 billion USD in net income for the fiscal year 2025.
Sumitomo Mitsui Financial Group+0.67%
09:02
The Danaher Northern China Joint Office has been launched in Peking, utilizing a shared workspace model.
DHR+0.04%
08:54
Daiichi Sankyo's datopotamab deruxtecan has been approved in Japan for the treatment of breast cancer.
Daiichi Sankyo+2.06%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.